3 hours HC Wainwright Reiterates Buy Rating for PDS Biotechnology (NASDAQ:PDSB)MarketBeat
HC Wainwright restated a “buy” rating and issued a $21.00 target price on shares of PDS Biotechnology in a research note on Thursday.
XHC Wainwright restated a “buy” rating and issued a $21.00 target price on shares of PDS Biotechnology in a research note on Thursday.
X